Tizanidine Hydrochloride
- Product NDC
- 73352-089
- 11-digit product format
- 733520089
- Labeler code
- 73352
- Product ID
- 73352-089_4bd048df-b403-70b2-e063-6394a90a7a38
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Trifluent Pharma, LLC
- Application
- ANDA213798
- Marketing category
- ANDA
- Marketing start
- 2025-09-16
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 8 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA], Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Tizanidine Hydrochloride
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| TIZANIDINE HYDROCHLORIDE | 8 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | B53E3NMY5C |
| Rxcui | 2723708 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 73352-089-60 | Tizanidine Hydrochloride | 60 in 1 BOTTLE | CAPSULE | 60 | | 3 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 73352-089-60 | 73352008960 | 60 CAPSULE in 1 BOTTLE (73352-089-60) | 60 capsule | 2025-09-16 | No | No | Current |